Announcements Trials
Browse Landscape

Phase

Phase 2 96Phase 1 39Phase 1/2 21Phase 3 18Phase EARLY_PHASE1 4Phase 4 4Phase 2/3 2Phase NA 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4

Conditions

Ovarian Neoplasms 4Carcinoma, Ovarian Epithelial 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × niraparib × Clear all
NCT06412120 2026-04-23

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

University of Miami

Phase 4 Recruiting
70 enrolled
Gynecologic

Ovarian Neoplasms

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

GlaxoSmithKline

Phase 4 Not yet recruiting
67 enrolled
Gynecologic

Ovarian Neoplasms

NCT03752216 2024-12-13

NiQoLe

ARCAGY/ GINECO GROUP

Phase 4 Completed
141 enrolled
Gynecologic

Ovarian Neoplasms

NCT05187208 2022-01-26

POLO

Seoul National University Hospital

Phase 4 Unknown
102 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡